Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2023 35
2024 5
2025 7
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
2023: Looking Back and Looking Ahead.
Li JZ, Clancy CJ, Singh U, Sears CL. Li JZ, et al. J Infect Dis. 2024 Mar 14;229(3):619-620. doi: 10.1093/infdis/jiae076. J Infect Dis. 2024. PMID: 38386686 Free article. No abstract available.
Functional Genomics of Antibiotic Susceptibility in Enterococcus faecalis From Infective Endocarditis.
Li Y, Stellfox ME, Evans KM, Mills EG, Squires KM, Dorazio AJ, Shields RK, Van Tyne D. Li Y, et al. J Infect Dis. 2025 Nov 14;232(5):1108-1118. doi: 10.1093/infdis/jiaf272. J Infect Dis. 2025. PMID: 40444324 Free PMC article.
We characterized 119 isolates from patients with EFIE in our health system from 2018 to 2023 genomically and phenotypically. Three genetic lineages (ST6, ST40, and ST179) accounted for 41% of all infections. ...
We characterized 119 isolates from patients with EFIE in our health system from 2018 to 2023 genomically and phenotypically. Three ge …
Trends and Patterns of HIV Transmitted Drug Resistance in China From 2018 to 2023.
Ye J, Dong Y, Lan Y, Chen J, Zhou Y, Liu J, Yuan D, Lu X, Guo W, Zheng M, Yang H, Song X, Liu C, Zhou Q, Zheng C, Guo Q, Yang X, Zhang L, Ge Z, Liu L, Yu F, Han Y, Huang H, Hao M, Ruan Y, Wu J, Li J, Chen Q, Ning Z, Ling X, Zhou C, Liu X, Bai J, Gao Y, Tong X, Zhou K, Mei F, Yang Z, Wang A, Wei W, Qiao R, Luo X, Huang X, Wang J, Shen X, Hu F, Zhang L, Tan W, Fan J, Tu A, Yu G, Fang Y, He S, Chen X, Wu D, Zhang X, Xin R, He X, Ren X, Xu C, Sun Y, Li Y, Liu G, Li X, Duan J, Huang T, Shao Y, Feng Y, Pan Q, Su B, Jiang T, Zhao H, Zhang T, Chen F, Hu B, Wang H, Zhao J, Cai K, Sun W, Gao B, Ning T, Liang S, Huo Y, Fu G, Li F, Lin Y, Xing H, Lu H. Ye J, et al. J Infect Dis. 2024 Dec 16;230(6):1410-1421. doi: 10.1093/infdis/jiae303. J Infect Dis. 2024. PMID: 39189826 Free article.
METHODS: We analyzed the demographic, clinical, and virologic data obtained from people with HIV (PWH) residing in 31 provinces of China who were newly diagnosed between 2018 and 2023. Evidence of TDR was defined by the World Health Organization list for surveillance of dr …
METHODS: We analyzed the demographic, clinical, and virologic data obtained from people with HIV (PWH) residing in 31 provinces of China who …
Long COVID After Bamlanivimab Treatment.
Evering TH, Moser CB, Jilg N, Yeh E, Sanusi B, Wohl DA, Daar ES, Li JZ, Klekotka P, Javan AC, Eron JJ, Currier JS, Hughes MD, Smith DM, Chew KW; ACTIV-2/A5401 Study Team. Evering TH, et al. J Infect Dis. 2023 Aug 31;228(Suppl 2):S126-S135. doi: 10.1093/infdis/jiad286. J Infect Dis. 2023. PMID: 37650236 Free PMC article. Clinical Trial.
Variant-Specific Viral Kinetics in Acute COVID-19.
Ribeiro RM, Choudhary MC, Deo R, Giganti MJ, Moser C, Ritz J, Greninger AL, Regan J, Flynn JP, Wohl DA, Currier JS, Eron JJ, Hughes MD, Smith DM, Chew KW, Daar ES, Perelson AS, Li JZ; ACTIV-2/A5401 Study Team. Ribeiro RM, et al. J Infect Dis. 2023 Aug 31;228(Suppl 2):S136-S143. doi: 10.1093/infdis/jiad314. J Infect Dis. 2023. PMID: 37650233 Free PMC article. Clinical Trial.
Immune Status and SARS-CoV-2 Viral Dynamics.
Li Y, Moser C, Aga E, Currier JS, Wohl DA, Daar ES, Ritz J, Greninger AL, Sieg S, Parikh UM, Coombs RW, Hughes MD, Eron JJ, Smith DM, Chew KW, Li JZ; ACTIV-2/A5401 Study Team. Li Y, et al. J Infect Dis. 2023 Aug 31;228(Suppl 2):S111-S116. doi: 10.1093/infdis/jiad200. J Infect Dis. 2023. PMID: 37650232 Free PMC article. Clinical Trial.
Vaccination Ameliorates Cellular Inflammatory Responses in SARS-CoV-2 Breakthrough Infections.
Huapaya JA, Higgins J, Kanth S, Demirkale CY, Gairhe S, Aboye EA, Regenold D, Sahagun SJ, Pastor G, Swaim D, Dewar R, Rehman T, Highbarger HC, Lallemand P, Laverdure S, Adelsberger J, Rupert A, Li W, Krack J, Teferi G, Kuruppu J, Strich JR, Davey R, Childs R, Chertow D, Kovacs JA, Barnett C, Torabi-Parizi P, Suffredini AF; COVID-ARC Study Group. Huapaya JA, et al. J Infect Dis. 2023 Jun 28;228(1):46-58. doi: 10.1093/infdis/jiad045. J Infect Dis. 2023. PMID: 36801946 Free PMC article.
A Model to Identify Gray Zone Patients With Chronic Hepatitis B Requiring Antiviral Therapy: A Multicenter Retrospective Study.
Yang XY, Li XD, Wu BY, Yang Q, Zheng YB, Zheng MH, Wu YP, Ma HY, Zuo J, Jia RX, Yu Y, Xu LY, Tian YX, An Q, Zhang T, He YL, Shi Y, Fan YC. Yang XY, et al. J Infect Dis. 2025 Aug 14;232(2):485-498. doi: 10.1093/infdis/jiaf070. J Infect Dis. 2025. PMID: 39960318 Free article.
METHODS: We retrospectively collected data on 200 gray zone patients not requiring AVT, according to assessment by noninvasive parameters from 2010 to 2023 in 6 hospitals, and randomized them into development (n = 140) and validation (n = 60) cohorts. ...
METHODS: We retrospectively collected data on 200 gray zone patients not requiring AVT, according to assessment by noninvasive parameters fr …
52 results